Contribution of stabilizing agents present in intravenous immunoglobulin preparations to modulation of mononuclear cell proliferation in vitro

Scandinavian Journal of Immunology

Volumn 44, Issue 6, 1996, Pages 585-591

  Alder, L B A ^a   Morgan, L A ^a,b   Spickett, G P ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CD3 ANTIGEN; GLYCINE; IMMUNOGLOBULIN G; MALTOSE; SUCROSE;

ADULT; ARTICLE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029800397     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-350.x     Document Type: Article

References (19)

1. Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1992;325:110-17.
2. Imbach P, Barandun S, D'Apuzzo V. High-dose intravenous gamma globulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;i:1228-30.
3. Newburger JW, Takahashi M, Burns JC et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med 1986;315:341-7.
4. Herlin T, Permin H, Pedersen F, Koch H. Intravenous immunoglobulin IgG: Mechanisms of action, preparations and side effects. LÆgeforeningens forlag, Copenhagen, 1993.
5. Atrah HI, Davidson RJL. Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias. J Clin Pathol 1988;41:1249-55.
6. Kawada K, Terasaki PI. Evidence for immunosupression by high-dose gammaglobulin. Exp Hematol 1987;15:133-6.
7. Klaesson S, Ringden, Markling M, Remburger M, Lundkvit I. Immune modulatory effects of immunoglobulins on cell-mediated Immune responses in vitro. Scand J Immunol 1993;38:477-84.
8. Van Schaik IN, Lundkvist I, Vermeulen M, Brand A. Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro. J Clin Immunol 1992;12:325-34.
9. Hashimoto F, Sakiyama Y, Matsumoto S. The suppressive effect of gammaglobulin preparations on in vitro pokeweed mitogen-induced immunoglobulin production. Clin Exp Immunol 1986;65:409-15.
10. Stohl W. Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use. J Immunol 1986;136:4407-13.
11. Andersson UG, Björk L, Skansen-Saphir U, Andersson JP. Down regulation of cytokine production and IL-2 receptor expression by pooled human IgG. Immunology 1993;79: 211-16.
12. Amran D, Renz H, Lack G, Bradley K, Gelfand EW. Suppression of cytokine-dependent human T cell proliferation by intravenous immunoglobulin. Clin Immunol Immunopathol 1994;73: 180-6.
13. Muchmore AV, Decker JM, Blaese RM. Evidence that specific oligosaccharides block early events necessary for the expression of antigen-specific proliferation by human lymphocytes. J Immunol 1980;125:1306-11.
14. MacCuish AC, Urbanik SJ, Campbell CJ, Duncan LJP, Irvine WJ. Phytohaemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients. Diabetes 1974;23:708-12.
15. Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved. Relevance to the increase susceptibility of diabetic patients to specific infection. Diabete Metabolisme 1992;18:187-201.
16. Berridge MJ. Inositol triphosphate and calcium signalling. Nature 1993;361:315-25.
17. Buchner K. Protein kinase C in the transduction of signals toward and within the cell nucleus Eur J Biochem 1995;228: 211-21.
18. Springer TA. The sensation and regulation of interactions with the extracellular environment: The cell biology of lymphocyte adhesion receptors. Annu Rev Cell Biol 1990;6:359-402.
19. Schwartz MA, Schalter MD, Ginsberg MH. Integrins: Emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995;11:549-99.